The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Capricor Therapeutics Inc shares valued at $14,999,998 were purchased by Nippon Shinyaku Co Ltd on Sep 20 ’24. At $5.36 per share, Nippon Shinyaku Co Ltd acquired 2,798,507 shares. The insider’s holdings grew to 7,090,351 shares worth approximately $117.13 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Musket David B purchased 410 shares, netting a total of over 1,128 in proceeds. Following the buying of shares at $2.75 each, the insider now holds 31,536 shares.
Before that, COLLIER EARL M JR had added 10,000 shares to its account. In a trade valued at $28,300, the Director bought Capricor Therapeutics Inc shares for $2.83 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.44 million.
As published in their initiating research note from Oppenheimer on May 17, 2024, Capricor Therapeutics Inc [CAPR] has been an Outperform and the price target has been revised to $14. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early January. As of October 26, 2022, Ladenburg Thalmann has initiated its “Buy” rating for CAPR. Earlier on December 26, 2018, Maxim Group downgraded its rating. Their new recommendation was “a Hold” for CAPR stock which previously was a “a Buy”.
Analyzing CAPR Stock Performance
During the last five days, there has been a surge of approximately 59.77%. Over the course of the year, Capricor Therapeutics Inc shares have jumped approximately 237.83%. Shares of the company reached a 52-week high of $18.14 on 10/01/24 and a 52-week low of $3.52 on 08/07/24. A 50-day SMA is recorded $5.45, while a 200-day SMA reached $5.20. Nevertheless, trading volume fell to 5.34 million shares from 12.84 million shares the previous day.
Support And Resistance Levels for Capricor Therapeutics Inc (CAPR)
According to the 24-hour chart, there is a support level at 14.73, which, if violated, would cause prices to drop to 12.94. In the upper region, resistance lies at 17.89. The next price resistance is at 19.27. RSI (Relative Strength Index) is 91.75 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 6.91, which suggests the price will increase in the coming days. Percent R is at 11.62%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Which companies own the most shares of Capricor Therapeutics Inc (CAPR)?
On January 26, 2018, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $8.60.
